Skip to content
Markets News
Stocks1 min read

Boston Scientific Shares Slip as Major Indexes Advance

Makkler Newsroom
October 2, 2026

The stock closed lower as the S&P 500, Dow and Nasdaq rose, with Boston Scientific’s next earnings report due October 28.

Boston Scientific shares closed at $42.60 on Friday, down 1.46% from the previous session. The S&P 500 rose 0.73%, the Dow gained 0.49% and the Nasdaq advanced 1.19%.

In the month leading up to the session, Boston Scientific shares had fallen 7.92%. The Medical sector was down 3.74% over the same period, while the S&P 500 rose 0.55%.

The company is scheduled to report quarterly results on October 28. Analysts expect earnings of $0.76 per share and revenue of $5.23 billion, up 1.33% and 3.25%, respectively, from a year earlier.

For the full year, Zacks consensus estimates call for earnings of $3.25 per share and revenue of $21.22 billion. Those figures would represent year-over-year increases of 6.21% and 5.72%. The consensus earnings estimate has fallen 1.3% over the past 30 days.

Boston Scientific’s forward P/E ratio was 13.28, compared with an industry average of 19.67. Its PEG ratio was 1.04, versus 1.71 for the Medical - Products industry.

Topics
Further reading

This article was produced with the help of AI technology. Based on reporting by the outlets listed above.

Comments (0)

Log in to join the discussion.Log in

No comments yet - be the first to weigh in.